Skip to main content
SciBX
Feature Story

Sex matters at the NIH

By Lauren Martz, Staff Writer

Sex matters at the NIH

For decades, the norm in preclinical research has been to use male animals for in vivo studies and ignore the sex of cells in in vitro studies for reasons of cost and convenience. The NIH wants to make the inclusion of both sexes the default in all preclinical studies and thinks the best way to alter entrenched habits is by focusing on grants and publications.

Full Article

Today's Biotech & Pharma News

Deep Brain Stimulation

Subscribe Now
Free Trial

Preclinical Results

There were no items published for this section in the most recent issue. Click more >> to read previously published items.